Skip to main content
Equibles

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in NVS — Novartis AG

CIK 1165408 Boston, MA
Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$38,483,693
-$925,807 QoQ
Shares Held
245,557
-4.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. NVS ranks #10 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 726,199 $871,024,939
2 JNJ
Johnson & Johnson
 2,566,595 $651,838,132
3 ABBV
AbbVie Inc.
 1,598,568 $402,263,651
4 MRK
Merck & Co., Inc.
 2,030,023 $260,857,955
5 AMGN
Amgen Inc
 471,833 $170,860,165
6 GILD
Gilead Sciences, Inc.
 1,071,977 $135,433,574
7 BMY
Bristol Myers Squibb Co
 1,716,000 $98,875,920
8 PFE
Pfizer Inc
 3,801,302 $91,535,352

All Filings in NVS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $38,483,693 245,557
2026-03-31 $39,409,500 258,000
2025-12-31 $13,812,919 100,188
2025-09-30 $26,954,509 210,188
2025-06-30 $1,752,345 14,481
2024-03-31 $31,296,894 323,549
2023-12-31 $39,829,837 394,472
2023-09-30 $31,777,467 311,972
2023-06-30 $24,057,751 238,408
2023-03-31 $12,142,528 131,984